Discussion of “Industrial Policy for Big Pharma” in the Washington Note. The point of the article seems to be that this poor industry, which happens to be one of three most profitable sectors in our economy, is somehow suffering from relatively few new drugs being approved in the last year. Something must be done!!!
A more relevant consideration, in my view, is how to afford the new technology–pricing of new drugs is beyond the means of our system. More on this in future posts.
Medicynic 